• Home
  • Randomize
  • Aim and mission
  • News
  • Newsletters
  • Contact
  • Organization (investigators, collaborators and funders)
  • Data requests
    • Publication policy CONTRAST
    • DATA REQUEST FORM (internal parties)
    • DATA REQUEST FORM (external parties)
  • Work packages info
    • WP1: Improving microvascular reperfusion
    • WP2: MR ASAP
    • WP3A: MR CLEAN LATE
    • WP3B: MR CLEAN MED
    • WP3C: MR CLEAN NO-IV
    • WP4: Dutch ICH pilot
    • WP5: Biobank
    • WP6: Clinical data management
    • WP7: Imaging data management
    • WP8: Logistics and epidemiology
    • WPYT: Young talent program
  • Investigators
    • Randomize for MR CLEAN NO-IV
    • Randomize for MR CLEAN-LATE
    • Randomize for MR CLEAN-MED
    • Include for Dutch ICH pilot
    • Access to Open Clinica
    • Access to XNAT
    • Newsletter
    • CONTRAST PLAZA
  • Documents
  • Ongoing Trials
  • Closed trials
  • Links


MR ASAP

WP Leaders: Bart van der Worp (UMC Utrecht) and Paul Nederkoorn (Amsterdam UMC)

Aim: To assess whether the treatment with glyceril trinitrate, started within 4. Hours after symptom onset in the prehospital setting, improves outcome in patients with AIS or ICH.

Click here form the MR ASAP website